Investing
Cathie Wood's ARK Invest Buys Over 530,000 Shares of Fate Therapeutics
Published:
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a sizable purchase on Wednesday. The fund bought over 530,000 shares of Fate Therapeutics Inc. (NASDAQ: FATE), as the price of this ETF was down over 2% on the day. Note that this fund is up significantly in the past year.
Specifically, ARK Innovation ETF (NYSEARCA: ARKK) bought 535,305 shares of Fate Therapeutics. At Wednesday’s closing price, this would have valued this purchase at roughly $46.2 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 60% in the past year.
Here’s a look at the other purchases across the ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | PATH | UiPath | 279,284 |
ARKG | SGFY | Signify Health | 53,916 |
ARKG | RXRX | Recursion Pharmaceuticals | 204,752 |
ARKG | RPTX | Repare Therapeutics | 18,190 |
ARKG | QSI | Quantum-Si | 359,389 |
ARKG | MASS | 908 Devices | 47,945 |
ARKK | FATE | Fate Therapeutics | 535,305 |
ARKK | COIN | Coinbase Global | 20,165 |
ARKK | TSLA | Tesla | 110,731 |
ARKQ | PATH | UiPath | 135,228 |
ARKW | VUZI | Vuzix | 521,151 |
ARKW | FTCH | Farfetch | 599,955 |
ARKX | AVAV | Aerovironment | 23,098 |
ARKX | PATH | UiPath | 25,645 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.
Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!
Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!
Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.